The global opioids market was valued at $18,532.8 million in 2018, and is expected to reach $22,387.2 million by 2026, registering a CAGR of 3.2% from 2019 to 2026

Wednesday, December 11, 2019 Drug News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, Dec. 11, 2019 /PRNewswire/ --

Opioids Market by Product (Codeine, Fentanyl, Methadone, Oxycodone, Morphine, Hydrocodone and Others) and Application (Pain Management, Cough Treatment, and Diarrhea): Global Opportunity Analysis and Industry Forecast, 2019-2026

Read the full report: https://www.reportlinker.com/p05828848/?utm_source=PRN

The global opioids market was valued at $18,532.8 million in 2018, and is expected to reach $22,387.2 million by 2026, registering a CAGR of 3.2% from 2019 to 2026. Opioids are drugs that stimulate the brain to produce a variety of effects, including pain relief. The term opioid refers to all substances (exogenous or endogenous) that possess morphine-like properties. Opioids are the most widely prescribed medications to treat moderate to severe chronic pain. These analgesics are used to manage pain in cancer patients and to treat severe constant pain in patients who suffer from terminal illnesses. The growth of the global opioids market is driven by alarming increase in incidence of orthopedic diseases & chronic pain. Furthermore, rise in disposable income and surge in global geriatric population are expected to propel the growth of the global opioids market. However, emergence and legalization of cannabis as an alternative to opioids impede the growth of the market. On the contrary, increase in consumption of opioid analgesic for pain management in developing countries is anticipated to create lucrative opportunities for market expansion in the near future. The global opioid market is segmented into product, application, and region. Depending on product, the market is categorized into codeine, fentanyl, methadone, oxycodone, morphine, and hydrocodone. The applications covered in the market include pain management, cough treatment, and diarrhea treatment. The pain management segment is further classified into neuropathic pain, migraine, back pain, osteoarthritis pain, cancer pain, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. KEY BENEFITS FOR STAKEHOLDERS - The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets. - It offers a quantitative analysis from 2018 to 2026, which is expected to enable the stakeholders to capitalize on prevailing market opportunities. - Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities. - Key players are profiled, and their strategies are analyzed thoroughly to understand the competitive outlook of the global market. KEY MARKET SEGMENTS By Product Type • Codeine • Fentanyl • Methadone • Oxycodone • Morphine • Hydrocodone By Application • Pain Management • Cough Treatment • Diarrhea Treatment By RegionNorth America o U.S. o Canada o MexicoEurope o UK o Germany o France o Spain o Russia o Rest of EuropeAsia-Pacific o China o Japan o India o Australis o South Korea o Taiwan o Rest of Asia-Pacific • LAMEA o Brazil o Saudi Arabia o South Africa o Rest of LAMEA LIST OF KEY PLAYERS PROFILED IN THE REPORT • Purdue Pharma • Boehringer Ingelheim • Janssen Pharmaceuticals, Inc. • Sanofi • Sun Pharmaceuticals • Mallinckrodt Pharmaceuticals • Endo Pharmaceuticals Inc. • Allergan, Plc • Pfizer, Inc.Read the full report: https://www.reportlinker.com/p05828848/?utm_source=PRN About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

Cision View original content:http://www.prnewswire.com/news-releases/the-global-opioids-market-was-valued-at-18-532-8-million-in-2018--and-is-expected-to-reach-22-387-2-million-by-2026--registering-a-cagr-of-3-2-from-2019-to-2026--300973070.html

SOURCE Reportlinker



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Diabetes Premium Membership Benefits

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store